Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2

Histone deacetylase 2 (HDAC2) is a chromatin modifier involved in epigenetic regulation of cell cycle, apoptosis and differentiation that is upregulated commonly in human hepatocellular carcinoma (HCC). In this study, we show that specific targeting of this HDAC isoform is sufficient to inhibit HCC...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Lee, Yun-Han, Seo, Daekwan, Choi, Kyung-Ju, Andersen, Jesper B., Won, Min-Ah, Kitade, Mitsuteru, Gómez-Quiroz, Luis E., Judge, Adam D., Marquardt, Jens U., Raggi, Chiara, Conner, Elizabeth A., MacLachlan, Ian, Factor, Valentina M., Thorgeirsson, Snorri S.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4155016/
https://ncbi.nlm.nih.gov/pubmed/24958469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-3531
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki